Beta
289118

Enhancing the Efficiency of Doxorubicin -Conjugated with gold nanocomposites for Active Targeting and Laser Treatment for Human Esophagus Cancer Cells

Article

Last updated: 01 Jan 2025

Subjects

-

Tags

Nanotechnology

Abstract

Nanotechnology is being used in cancer treatment to deliver drugs to tumors, improve imaging, and detect cancer cells. Nanoparticles are being used to deliver drugs more effectively to tumors, while also reducing the side effects of the drugs. The current context shows the conceivable biomedical utility of gold nanoparticles (AuNPs) covered with doxorubicin (DOX) for double chemotherapy and photothermal therapy (PTT) of throat cancers (esophagus) in vitro. DOX as FDA-authorized anti-cancer drug was added to AuNPs to enhance the chemotherapy impact. The blended DOX - AuNPs showed exorbitant cytotoxicity at the cancer cells and strong light absorption for temperature expansion in vitro. In the wake of treating DOX– Au nanocomposites with inside the esophagus cell line, PTT-helped DOX-Au nanocomposites involved the fantastical cytotoxicity of the cell strains for 15 min after the laser treatment. Exceptionally cytotoxicity impact in esophagus cell line turned out to be more attractive due to specific light absorption with the aid of using the directed DOX-Au nanocomposites. Thusly, the proposed DOX-Au nanocomposites might be an ability nano-theranostic material for treating throat cancers. The gene expression levels withinside the esophagus cell line from every group with or without laser exposure have been compared individually with control group. Bax has been overexpressed in esophagus cell line organization post 15 min laser irradiation. Conversely, BCL-2 gene has been down regulated with the aid of using RT-PCR analysis post 15 min laser irradiation, while in comparison to control cell line.

DOI

10.21608/ejchem.2023.191302.7548

Keywords

Laser, PTT, gold /DOX Nanocomposites, RT-PCR

Authors

First Name

Mahmoud

Last Name

Moawad

MiddleName

-

Affiliation

Pathology Dept., National Cancer Institute, Cairo Univ. Egypt

Email

mahmoud.moawad@nci.cu.edu.eg

City

-

Orcid

0000-0003-3250-7925

First Name

Ahmed M.

Last Name

Fahmy

MiddleName

-

Affiliation

Pathology Dept., National Cancer Institute, Cairo Univ. Egypt

Email

-

City

-

Orcid

-

First Name

El-Sayed A.

Last Name

Elsherbeni

MiddleName

-

Affiliation

National Institute of Laser Enhanced Science, Cairo University, Giza, Egypt.

Email

elsayed@niles.edu.eg

City

Giza

Orcid

0002-9477-3113

First Name

Ahmed M.

Last Name

Youssef

MiddleName

-

Affiliation

Packaging Materials Department, National Research Centre, 33 El Bohouth St. (former El Tahrirst.), Dokki, Giza, Egypt, P.O. 12622

Email

amyoussef27@yahoo.com

City

-

Orcid

-

First Name

Gamal

Last Name

El-Ghannam

MiddleName

-

Affiliation

National Institute of Laser Enhanced Science, Cairo University, Giza, Egypt.

Email

gamalniles@gmail.com

City

Giza

Orcid

0000-0001-8393-0649

Volume

66

Article Issue

10

Related Issue

43169

Issue Date

2023-10-01

Receive Date

2023-02-02

Publish Date

2023-10-01

Page Start

17

Page End

22

Print ISSN

0449-2285

Online ISSN

2357-0245

Link

https://ejchem.journals.ekb.eg/article_289118.html

Detail API

https://ejchem.journals.ekb.eg/service?article_code=289118

Order

289,118

Type

Original Article

Type Code

297

Publication Type

Journal

Publication Title

Egyptian Journal of Chemistry

Publication Link

https://ejchem.journals.ekb.eg/

MainTitle

Enhancing the Efficiency of Doxorubicin -Conjugated with gold nanocomposites for Active Targeting and Laser Treatment for Human Esophagus Cancer Cells

Details

Type

Article

Created At

30 Dec 2024